Hedge Fund - Indaba Capital Management
Standard Biotools Inc. (LAB) NOTE 5.250%12/0
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $0 | 0% | 0 | $1.86 |
| 2 | 2024 - Q3 (2024-09-30) | $7,631,658 | 3.26% | 7,660,000 | $1.96 |
| 3 | 2024 - Q2 (2024-06-30) | $0 | 0% | 0 | $2.44 |
| 4 | 2024 - Q1 (2024-03-31) | $25,715,391 | 16.78% | 23,190,000 | $2.41 |
| 5 | 2023 - Q4 (2023-12-31) | $43,411,950 | 24.92% | 40,500,000 | $2.13 |
| 6 | 2023 - Q3 (2023-09-30) | $48,701,250 | 14.35% | 40,500,000 | $2.62 |
| 7 | 2023 - Q2 (2023-06-30) | $42,597,900 | 14.41% | 40,500,000 | $1.97 |
| 8 | 2023 - Q1 (2023-03-31) | $34,093,943 | 10.54% | 32,748,000 | $1.98 |
| 9 | 2022 - Q4 (2022-12-31) | $29,090,048 | 5.62% | 32,748,000 | $1.23 |
| 10 | 2022 - Q3 (2022-09-30) | $29,460,000 | 4.53% | 32,748,000 | $1.51 |
| 11 | 2022 - Q2 (2022-06-30) | $30,619,000 | 4.02% | 32,748,000 | $2.47 |
| 12 | 2022 - Q1 (2022-03-31) | $40,489,000 | 4.58% | 28,133,000 | $3.45 |
| 13 | 2021 - Q4 (2021-12-31) | $43,634,000 | 4.67% | 28,133,000 | $4.68 |
| 14 | 2021 - Q3 (2021-09-30) | $68,121,000 | 7.21% | 28,133,000 | $6.58 |
| 15 | 2021 - Q2 (2021-06-30) | $64,757,000 | 6.99% | 28,133,000 | $5.35 |
| 16 | 2021 - Q1 (2021-03-31) | $49,185,000 | 6.18% | 28,133,000 | $5.49 |
| 17 | 2020 - Q4 (2020-12-31) | $61,423,000 | 10.83% | 28,133,000 | $6.57 |
The displayed share prices are average quarterly stock market prices.